Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07455058) titled 'Water Vapor Ablation for Prostate Cancer: Long-Term Registry' on Feb. 26.

Study Type: Observational [Patient Registry]

Primary Sponsor: Francis Medical Inc.

Condition: Prostate Cancer

Intervention: Device: Vanquish Therapy

Recruitment Status: Not recruiting

Date of First Enrollment: April 30, 2026

Target Sample Size: 2500

To know more, visit https://clinicaltrials.gov/study/NCT07455058

Published by HT Digital Content Services with permission from Health Daily Digest....